Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nabriva Therapeutics plc (“Nabriva” or the “Company”) (NASDAQ:NBRV).
NEW YORK, May 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nabriva Therapeutics plc (“Nabriva” or the “Company”) (NASDAQ:NBRV). If you invested in Nabriva stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/NBRV. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. CONTACT: Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. View original content to download multimedia:http://www.prnewswire.com/news-releases/nabriva-investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-50-000-investing-in-nabriva-therapeutics-plc-to-contact-the-firm-300844643.html SOURCE Faruqi & Faruqi, LLP | ||
Company Codes: NASDAQ-NMS:NBRV |